Botox (onabotulinumtoxinA) mechanism of action von Brin, Mitchell F., Burstein, Rami

Volltext

Entering the 4th decade of Botox (onabotulinumtoxinA): A narrative review of its development and impact on patients and medicine von Brin, Mitchell F.

Volltext

The pluripotential evolution and journey of Botox (onabotulinumtoxinA) von Brin, Mitchell F., Blitzer, Andrew

Volltext

Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impact von Jankovic, Joseph, Tsui, Joseph, Brin, Mitchell F.

Volltext

Update on Non-Interchangeability of Botulinum Neurotoxin Products von Brin, Mitchell F, Nelson, Mariana, Ashourian, Nazanin, Brideau-Andersen, Amy, Maltman, John

Volltext

Modulation of amygdala activity for emotional faces due to botulinum toxin type A injections that prevent frowning von Stark, Shauna, Stark, Craig, Wong, Brian, Brin, Mitchell F.

Volltext

Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12-year experience in more than 900 patients von Blitzer, Andrew, Brin, Mitchell F., Stewart, Celia F.

Volltext

Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies von Aurora, Sheena K., Brin, Mitchell F.

Volltext

Botulinum neurotoxins: Future innovations von Brideau-Andersen, Amy, Dolly, J. Oliver, Brin, Mitchell F.

Volltext

Early development history of Botox (onabotulinumtoxinA) von Scott, Alan B., Honeychurch, Dennis, Brin, Mitchell F.

Volltext

Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review von Burstein, Rami, Blumenfeld, Andrew M., Silberstein, Stephen D., Manack Adams, Aubrey, Brin, Mitchell F.

Volltext

Development of future indications for BOTOX von Brin, Mitchell F.

Volltext

Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains von Burstein, Rami, Zhang, XiChun, Levy, Dan, Aoki, K Roger, Brin, Mitchell F

Volltext

Basic and clinical aspects of BOTOX von Brin, Mitchell F.

Volltext

Treatment of pediatric spasticity, including children with cerebral palsy, with Botox (onabotulinumtoxinA): Development, insights, and impact von Gormley, Mark, Chambers, Henry G., Kim, Heakyung, Leon, Judith, Dimitrova, Rozalina, Brin, Mitchell F.

Volltext

Reply: “Abbreviations for Device Names: a Proposed Methodology With Specific Examples”—Dermatol Surg 2013;1–3 von Brin, Mitchell F, Maltman, John

Volltext

Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30‐year experience von Blitzer, Andrew, Brin, Mitchell F., Simonyan, Kristina, Ozelius, Laurie J., Frucht, Steven J.

Volltext

Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology von Brin, Mitchell F.

Volltext

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program von Dodick, David W., Turkel, Catherine C., DeGryse, Ronald E., Aurora, Sheena K., Silberstein, Stephen D., Lipton, Richard B., Diener, Hans-Christoph, Brin, Mitchell F.

Volltext

Atogepant – an orally-administered CGRP antagonist – attenuates activation of meningeal nociceptors by CSD von Strassman, Andrew M, Melo-Carrillo, Agustin, Houle, Timothy T, Adams, Aubrey, Brin, Mitchell F, Burstein, Rami

Volltext